NEUCA S.A. (WSE: NEU)

Market Cap	3.69B
Revenue (ttm)	12.34B
Net Income (ttm)	161.38M
Shares Out	4.47M
EPS (ttm)	35.59
PE Ratio	23.24
Forward PE	16.74
Dividend	14.50 (1.77%)
Ex-Dividend Date	Jun 12, 2024

Volume	113
Average Volume	815
Open	837.00
Previous Close	837.00
Day's Range	825.00 - 842.00
52-Week Range	730.00 - 969.00
Beta	0.45
RSI	35.02
Earnings Date	Mar 28, 2025

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 4,633
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2023, NEUCA's revenue was 11.81 billion, an increase of 5.17% compared to the previous year's 11.23 billion. Earnings were 146.27 million, an increase of 6.58%.